An investigational autologous engineered T-cell therapy for HLA-A*02 positive patients with myxoid/round cell liposarcoma expressing the NY-ESO-1 antigen.
An investigational autologous engineered T-cell therapy for HLA-A*02 positive patients with myxoid/round cell liposarcoma expressing the NY-ESO-1 antigen.